Related Experiment Videos
Deterioration of renal function during angiotensin converting enzyme inhibition in hypertensive patients with a
Insights
Angiotensin converting enzyme inhibitors like Captopril can decrease glomerular filtration rate (GFR) in hypertensive patients with reduced kidney function. This GFR reduction is reversible and linked to the drug
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Pharmacology
Background:
- Hypertension and reduced renal function can compromise glomerular filtration rate (GFR).
- The renin-angiotensin system plays a crucial role in regulating renal hemodynamics.
- Angiotensin converting enzyme (ACE) inhibitors interfere with angiotensin II formation.
Purpose of the Study:
- To investigate the effect of ACE inhibition on GFR in patients with compromised renal function.
- To explore the role of the renin-angiotensin system in maintaining GFR under specific conditions.
Main Methods:
- Observational study involving unilaterally nephrectomized hypertensive patients.
- Administration of Captopril (an ACE inhibitor) and monitoring of GFR and blood pressure.
- Assessment of GFR changes upon cessation of Captopril treatment.
Main Results:
- A significant decrease in GFR was observed in three out of four patients with poorly functioning kidneys.
- The decline in GFR was independent of blood pressure changes and reversed upon Captopril withdrawal.
- One patient with initially normal GFR showed no change after Captopril administration.
Conclusions:
- ACE inhibition can functionally reduce GFR in patients with renal insufficiency and hypertension.
- GFR maintenance can critically depend on the renin-angiotensin system when renal perfusion is reduced.
- Inhibition of angiotensin II formation may impair GFR in specific patient populations.
Abstract:
During treatment with the angiotensin converting enzyme inhibitor, Captopril, glomerular filtration rate (GFR) decreased in three unilaterally nephrectomized hypertensive patients with a poorly functioning remaining kidney. The fall in GFR was not related to changes in the blood pressure, and was reversed when Captopril was stopped. In a fourth nephrectomized patient the initially normal GFR was not affected by captopril. These observations point to a functional reduction in GFR due to a withdrawal of an intrarenal action of angiotensin II. Maintenance of GFR may become critically dependent on a functioning renin-angiotensin system when renal perfusion pressure is reduced to a certain degree. Inhibition of angiotensin II formation may lead to a decrease in GFR in patients with renal hypertension and pre-existing renal insufficiency.